Maxim Group Reaffirms Their Buy Rating on Neurosense Therapeutics Ltd. (NRSN)
TipRanksAug 17, 2023 15:15 ET
Alliance Global Partners Initiates Coverage On NeuroSense Therapeutics With Buy Rating, Announces Price Target of $7.5
BenzingaJul 17, 2023 10:25 ET
NeuroSense Therapeutics Analyst Ratings
BenzingaJul 17, 2023 10:24 ET
Maxim Group Keeps Their Buy Rating on Neurosense Therapeutics Ltd. (NRSN)
TipRanksJun 14, 2023 15:15 ET
Neurosense Therapeutics Ltd. (NRSN) Gets a Buy From Maxim Group
TipRanksJun 3, 2023 11:45 ET
Analysts Are Bullish on These Healthcare Stocks: UniQure (QURE), Neurosense Therapeutics Ltd. (NRSN)
TipRanksMay 16, 2023 10:50 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: EyePoint Pharmaceuticals (EYPT), Qiagen (QGEN) and Neurosense Therapeutics Ltd. (NRSN)
TipRanksMay 4, 2023 10:52 ET
Maxim Group Reaffirms Their Buy Rating on Neurosense Therapeutics Ltd. (NRSN)
TipRanksMar 25, 2023 10:36 ET
Neurosense Therapeutics Ltd. (NRSN) Gets a Buy From Maxim Group
TipRanksFeb 8, 2023 07:40 ET
Maxim Group Sticks to Its Buy Rating for Neurosense Therapeutics Ltd. (NRSN)
TipRanksJan 20, 2023 12:10 ET
Maxim Group Sticks to Their Buy Rating for Neurosense Therapeutics Ltd. (NRSN)
TipRanksDec 2, 2022 12:05 ET
Analysts Are Bullish on These Healthcare Stocks: Gamida Cell (GMDA), Neurosense Therapeutics Ltd. (NRSN)
TipRanksSep 29, 2022 11:25 ET
Analysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX), Biophytis (BPTS) and Neurosense Therapeutics Ltd. (NRSN)
TipRanksSep 7, 2022 11:35 ET
Neurosense Therapeutics Ltd. (NRSN) Gets a Buy Rating from Maxim Group
TipRanksJun 28, 2022 12:43 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aeglea Biotherapeutics (AGLE) and Neurosense Therapeutics Ltd. (NRSN)
TipRanksJun 2, 2022 17:23 ET
No Data
No Data